Transcription Factor Expression in the Developing Human Fetal Endocrine Pancreas
Overview
Affiliations
Aims/hypothesis: Morphological changes that occur during pancreatic endocrine cell differentiation have been shown in rodent systems to be dependent on sequential alterations in transcription factor expression. However, similar data for humans have been limited. The aim of the present study was to provide a connection between pancreatic morphology, transcription factor gene expression and protein localisation during human fetal development.
Methods: Human fetal pancreases were examined at early (8-12 weeks of fetal age), middle (14-16 weeks) and late (19-21 weeks) stages, using immunohistological, microarray and qRT-PCR analyses.
Results: We observed a significant decrease in pancreatic duodenal homeobox 1 (PDX-1)(+)/cytokeratin 19(+) cells (p < 0.001), with a simultaneous increase in PDX-1(+)/insulin(+) cells from 8 to 21 weeks (p < 0.05). Increased PDX-1/insulin co-localisation within islet clusters was noted, while no co-expression of PDX-1 with glucagon was found, suggesting that loss of PDX-1 is essential for alpha cell formation. Given that neurogenin 3 (NGN3) expression is critical for establishing the endocrine cell programme in the rodent pancreas, we examined its expression pattern and co-localisation in PDX-1(+), insulin(+) and glucagon(+) cells. Co-localisation of NGN3 with PDX-1, insulin and glucagon was noted during early development, with significant decreases in middle and late stages (p < 0.001). Our microarray and co-localisation analyses of transcription factors linked to NGN3 demonstrated that ISL1 transcription factor (ISL1), neurogenic differentiation 1 (NEUROD1), NK2 related transcription factor related, locus 2 (NKX2-2) and paired box gene 6 (PAX6) were upregulated during development and present in all four endocrine cell types, while NK6 related transcription factor related, locus 1 (NKX6-1) was expressed exclusively in beta cells.
Conclusions/interpretation: This study is an important step towards identifying key molecular factors involved in development of the human fetal endocrine pancreas.
Epigenetic modulation of cell fate during pancreas development.
Bele S, Wokasch A, Gannon M Trends Dev Biol. 2024; 16:1-27.
PMID: 38873037 PMC: 11173269.
Badr O, Kamal M, El-Maraghy S, Ghaiad H Biol Res. 2024; 57(1):20.
PMID: 38698488 PMC: 11067316. DOI: 10.1186/s40659-024-00502-4.
Xie G, Toledo M, Hu X, Yong H, Sanchez P, Liu C BMC Genomics. 2024; 25(1):427.
PMID: 38689254 PMC: 11059690. DOI: 10.1186/s12864-024-10335-w.
An Insight into Vital Genes Responsible for β-cell Formation.
Narayan G, Ronima K R , Agrawal A, Thummer R Adv Exp Med Biol. 2023; 1450:1-27.
PMID: 37432546 DOI: 10.1007/5584_2023_778.
Pancreatic β-cell heterogeneity in adult human islets and stem cell-derived islets.
Aldous N, Moin A, Abdelalim E Cell Mol Life Sci. 2023; 80(6):176.
PMID: 37270452 PMC: 10239390. DOI: 10.1007/s00018-023-04815-7.